Upregulation of MUC5AC in CRC cells has recently been confirmed as a mechanism for resistance to 5-FU and oxaliplatin chemotherapy through down-regulation of p53 and up-regulation of β-catenin [66]. This evidence concerns the gene MUC5AC and colorectal carcinoma.